JACKSONVILLE, Florida & NASHVILLE, Tennessee—Forcura, the intelligent workflow management company, and Medalogix, a clinical decision support company, announced that they have combined. Together, the companies will create a post-acute care technology platform focused on the advancement of intelligent patient care within home-based care providers and ultimately across the entire health care continuum.
Berkshire Partners (Berkshire) will be the majority owner of the combined organization, and The Vistria Group (Vistria) will be the largest minority shareholder in the transaction.
The strategic combination of Forcura and Medalogix will allow providers to leverage one platform to streamline patient care transitions, simplify collaboration with the broader care team, optimize utilization and resource allocation, and improve end-of-life care management. The new company’s products will make patient care journeys more transparent for referral sources and payers, leverage artificial intelligence (AI) to calibrate patient care delivery, improve outcomes and drive better business performance for post-acute care providers and their cross-continuum partners.
Post-acute care is a critical part of the United States health care landscape but is often siloed, resulting in fragmented care delivery for patients and a challenging environment for providers, the companies said. The combined platform will seek to transform how patients experience post-acute care, better connect these providers into the broader health care ecosystem, and enable more equitable reimbursements that sustain and elevate the post-acute care sector as health care continues to shift further toward value-based care.
“We look forward to our next chapter with Medalogix, where we sustain our commitment to empower better patient care and elevate the role of post-acute providers across the health care continuum,” said Craig Mandeville, Founder and CEO of Forcura. Annie Erstling, Forcura’s new president and chief transformation officer, added, “This investment from Berkshire and Vistria will accelerate our joint development, alongside Medalogix, of a groundbreaking post-acute care technology platform that drives significant value for providers, payers and patients.”
Mandeville will sit on the Board of Directors of the combined business.
“From day one, we have believed that the future of health care is in the home,” said Elliott Wood, CEO of Medalogix who will become CEO of the combined business. “We’re excited to join forces with Forcura to maximize the reach and impact of our clinical decision support technology and help evolve how providers care for patients and guide them to the best care setting while also achieving operational excellence. Ultimately, our goal is to help forge a stronger post-acute sector so more patients can receive care where they want it most—at home.”
“We have long admired both Forcura and Medalogix and the vital role they play in the post-acute care ecosystem. We are thrilled to bring these companies together to help create a leading technology platform that solves real pain points for providers and other stakeholders and ultimately helps to drive better patient care,” said Sam Spirn, managing director at Berkshire Partners.
“We look forward to building a leading organization focused on growth and innovation that aims to deliver significant value to customers across the health care continuum,” continued Jon Nuger, managing director at Berkshire Partners.
“We are thrilled to be a part of the next chapter of Medalogix’s journey with Forcura," said David Schuppan, senior partner and co-head of Healthcare at The Vistria Group. "Their combined capabilities will continue to be transformative for enabling superior in-home care delivery effectiveness and efficiency; ensuring patients receive the right care at the right time in their preferred setting."
Kirkland & Ellis LLP served as legal counsel to Forcura and Accel KKR on the transaction. Houlihan Lokey served as the exclusive financial advisor to Forcura and Accel KKR. Ropes & Gray LLP served as legal counsel to Medalogix and Vistria. William Blair served as the exclusive financial advisor to Medalogix and Vistria.